Seer, Inc.
NasdaqGS:SEER
Sector
Location
Market Cap
USD 127.70 M
Share Price
USD 2.17
Avg Daily Volume
246,367
Change (1 day)
-0.46%
Change (1 year)
10.15%
Change (YTD)
-6.06%
Seer, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -47.07 M
Seer, Inc. Operating Cash Flow is USD -47.07 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -6.22% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Seer, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -50.19 M, a -17.67% change year over year.
-
Seer, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -60.96 M, a 20.41% change year over year.
-
Seer, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -50.63 M, a 65.30% change year over year.
-
Seer, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -30.63 M.
StockViz
Competitors
Lyell Immunopharma, Inc.
USD 12.44
LYEL
-0.43
-3.34%
Generation Bio Co.
NA
GBIO
Nurix Therapeutics, Inc.
USD 11.88
NRIX
-0.01
-0.08%
ORIC Pharmaceuticals, Inc.
USD 10.71
ORIC
-0.33
-2.99%
MediciNova, Inc.
USD 1.35
MNOV
+0.02
1.50%
PepGen Inc.
USD 1.38
PEPG
0.00%
Monte Rosa Therapeutics, Inc.
USD 5.58
GLUE
+0.32
6.08%
Mineralys Therapeutics, Inc.
USD 14.49
MLYS
+0.61
4.40%
AN2 Therapeutics, Inc.
USD 1.07
ANTX
-0.01
-0.93%
Pharvaris N.V.
USD 19.79
PHVS
+0.18
0.92%
Sana Biotechnology, Inc.
USD 4.36
SANA
-0.09
-2.02%
Kymera Therapeutics, Inc.
USD 44.07
KYMR
+0.37
0.85%
Cullinan Oncology, Inc.
USD 8.16
CGEM
-0.18
-2.16%
Foghorn Therapeutics Inc.
USD 5.45
FHTX
-0.46
-7.78%
C4 Therapeutics, Inc.
USD 2.16
CCCC
-0.09
-4.00%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Lyell Immunopharma, Inc.
USD 12.44
LYEL
-0.43
-3.34%
Generation Bio Co.
NA
GBIO
Nurix Therapeutics, Inc.
USD 11.88
NRIX
-0.01
-0.08%
ORIC Pharmaceuticals, Inc.
USD 10.71
ORIC
-0.33
-2.99%
MediciNova, Inc.
USD 1.35
MNOV
+0.02
1.50%
PepGen Inc.
USD 1.38
PEPG
0.00%
Monte Rosa Therapeutics, Inc.
USD 5.58
GLUE
+0.32
6.08%
Mineralys Therapeutics, Inc.
USD 14.49
MLYS
+0.61
4.40%
AN2 Therapeutics, Inc.
USD 1.07
ANTX
-0.01
-0.93%
Pharvaris N.V.
USD 19.79
PHVS
+0.18
0.92%
Sana Biotechnology, Inc.
USD 4.36
SANA
-0.09
-2.02%
Kymera Therapeutics, Inc.
USD 44.07
KYMR
+0.37
0.85%
Cullinan Oncology, Inc.
USD 8.16
CGEM
-0.18
-2.16%
Foghorn Therapeutics Inc.
USD 5.45
FHTX
-0.46
-7.78%
C4 Therapeutics, Inc.
USD 2.16
CCCC
-0.09
-4.00%